Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial

por Gonzalez-Miro, Majela, Pawlowski, Andrzej, Lehtonen, Janne, Cao, Duojia, Larsson, Sara, Darsley, Michael, Kitson, Geoff, Fischer, Per B., Johansson-Lindbom, Bengt
Publicado 2023

A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains

por Pawlowski, Andrzej, Lannergård, Jonas, Gonzalez-Miro, Majela, Cao, Duojia, Larsson, Sara, Persson, Jenny J., Kitson, Geoff, Darsley, Michael, Rom, Ane Lilleøre, Hedegaard, Morten, Fischer, Per B., Johansson-Lindbom, Bengt
Publicado 2022

Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge

por Harro, Clayton, Louis Bourgeois, A., Sack, David, Walker, Richard, DeNearing, Barbara, Brubaker, Jessica, Maier, Nicole, Fix, Alan, Dally, Len, Chakraborty, Subhra, Clements, John D., Saunders, Ingelise, Darsley, Michael J.
Publicado 2019

An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli

por Porter, Chad K., Riddle, Mark S., Alcala, Ashley N., Sack, David A., Harro, Clayton, Chakraborty, Subhra, Gutierrez, Ramiro L., Savarino, Stephen J., Darsley, Michael, McKenzie, Robin, DeNearing, Barbara, Steinsland, Hans, Tribble, David R., Bourgeois, A. Louis
Publicado 2016

Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection

por Chakraborty, Subhra, Randall, Arlo, Vickers, Tim J., Molina, Doug, Harro, Clayton D., DeNearing, Barbara, Brubaker, Jessica, Sack, David A., Bourgeois, A. Louis, Felgner, Philip L., Liang, Xiaowu, Mani, Sachin, Wenzel, Heather, Townsend, R. Reid, Gilmore, Petra E., Darsley, Michael J., Rasko, David A., Fleckenstein, James M.
Publicado 2019